Arcturus Therapeutics

PriceArcturus Therapeutics

ARCT

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Historical stock price chart and annual return over the past years

-85%

5 years

% Total

ARCT
-31%

5 years

Annual Return

ARCT